Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer

By Wist Erik Andreas   Sommer Hilde Heen   Østenstad Bjørn   Risberg Terje   Fjæstad Knut  

Acta Oncologica, Vol. 43, Iss. 1, 2004-03 ,pp. : 11-14

Informa Healthcare

Access to resources Recommend Favorite

Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer

By Robain M.   Pierga J.Y.   Jouve M.   Asselain B.   Dieras V.   Beuzeboc P.   Palangie T.   Dorval T.   Extra J.-M.   Scholl S.   Pouillart P.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2301-2312

Elsevier

Access to resources Recommend Favorite

Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer

By Klintman Marie  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 365-371

Springer Publishing Company

Access to resources Recommend Favorite

Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

By Hatschek T.   Carlsson L.   Einbeigi Z.   Lidbrink E.   Linderholm B.   Lindh B.   Loman N.   Malmberg M.   Rotstein S.   Söderberg M.   Sundquist M.   Walz T.   Hellström M.   Svensson H.   Åström G.   Brandberg Y.   Carstensen J.   Fernö M.   Bergh J.  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 939-947

Springer Publishing Company

Access to resources Recommend Favorite

First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 987-993

Spandidos Publications

Access to resources Recommend Favorite